Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-230.09%EBITDA Margin
VS
Market
Sector
Industry
History
$ 0.2Close
$ 0.04 - $ 0.84 52-Week Range
Ticker Information
Ticker
ADAPCompany Name
ADAPTIMMUNE THERAPEUTICS PLCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQADAPTIMMUNE THERAPEUTICS PLC - EBITDA Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ADAP - EBITDA % Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -149.75M | -230.09% | $ 65.08M |
| 3/31/2025 | $ -50.18M | -27.93% | $ 179.64M |
| 12/31/2024 | $ -52.66M | -29.58% | $ 178.03M |
| 9/30/2024 | $ -30.39M | -17.36% | $ 175.04M |
| 6/30/2024 | $ -59.56M | -42.1% | $ 141.46M |
| 3/31/2024 | $ -151.35M | -824.43% | $ 18.36M |
| 12/31/2023 | $ -102.69M | -170.36% | $ 60.28M |
| 9/30/2023 | $ -83.81M | -117.92% | $ 71.08M |
| 6/30/2023 | $ -81.32M | -114.92% | $ 70.77M |
| 3/31/2023 | $ -105.34M | -148.01% | $ 71.17M |
Key Performance Insights, Last 5 Years
- ADAPTIMMUNE THERAPEUTICS PLC's latest trailing twelve months (TTM) EBITDA % stands at -3601.85%.
- Over the past 5 years, ADAPTIMMUNE THERAPEUTICS PLC's average EBITDA % has been -1194.44%.
- The median EBITDA % for ADAPTIMMUNE THERAPEUTICS PLC during this period was -701.15%
- ADAPTIMMUNE THERAPEUTICS PLC reached its highest EBITDA % over the past 5 years at -17.36%.
- The lowest EBITDA % recorded by ADAPTIMMUNE THERAPEUTICS PLC in the same timeframe -3639.74%
ADAPTIMMUNE THERAPEUTICS PLC's EBITDA % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA % Benchmarks
Similar metrics to Revenues:
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
Definition of EBITDA Margin
[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.EBITDA / Revenues
(=) EBITDA % EBITDA % for ADAPTIMMUNE THERAPEUTICS PLC is calculated as follows: EBITDA [ $ -114.68M ] / Revenues [ $ 3.18M ]
(=) EBITDA % [ -3601.85% ] ADAP - EBITDA Margin, Last 5 years
-3639.74%
Minimum
Mar 31, 2021
-17.36%
Maximum
Sep 30, 2024
-1194.44%
Average
-701.15%
Median
EBITDA % Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.12% with a standard deviation of 26.88%.
The following table provides additional summary stats:
EBITDA % in the Market:
| filtered constituents | 3.29K |
|---|---|
| min | -75.07% |
| max | 97.73% |
| average | 16.12% |
| median | 14.72% |
| std | 26.88% |